Celanese Corp. 10-Q Summary: Q2 2026
Business Context and Reporting Period
This summary covers Celanese Corporation's Form 10-Q for the quarterly period ended June 30, 2026. Celanese is a global chemical and specialty materials company operating primarily through two segments: Engineered Materials (high-performance polymers) and Acetyl Chain (intermediate chemicals). The company is currently focused on deleveraging, cost optimization, and managing a challenging macroeconomic environment.
Key Financial Metrics
| Metric | Q2 2026 (3 Months) | Q2 2025 (3 Months) | YTD 2026 (6 Months) | YTD 2025 (6 Months) |
|---|---|---|---|---|
| Net Sales ($ millions) | 2,752 | 2,532 | 5,089 | 4,921 |
| Operating Profit ($ millions) | 276 | 231 | 490 | 396 |
| Net Earnings Attributable to Celanese ($ millions) | 125 | 197 | 169 | 173 |
| Diluted EPS ($) | 1.13 | 1.80 | 1.54 | 1.58 |
| Operating Margin (%) | 10.0% | 9.1% | 9.6% | 8.0% |
| Free Cash Flow Proxy (Operating Cash Flow) ($ millions) | N/A | N/A | 285 | 447 |
| Total Debt ($ millions) | 12,007 | N/A | 12,007 | 12,598 |
| Cash and Equivalents ($ millions) | 1,364 | N/A | 1,364 | 1,263 |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 9% in Q2 and 3% YTD compared to 2025. Growth was driven by higher pricing in the Acetyl Chain segment (due to supply dislocation) and Engineered Materials (pricing actions and mix), partially offset by lower volumes following the sale of the Micromax business.
- Profitability: Operating profit improved significantly (19% in Q2, 24% YTD) due to sales growth and a $50 million gain on the sale of the Micromax business. However, this was offset by $85 million in accelerated depreciation related to plant closures (Lanaken, Belgium; Sakra, Singapore; Ulsan, South Korea) and higher raw material costs in the Acetyl Chain.
- Cash Flow: Operating cash flow decreased to $285 million YTD (from $447 million in 2025) primarily due to unfavorable working capital changes ($396 million impact from receivables and inventory). Investing cash flow turned positive ($366 million) due to the $493 million proceeds from the Micromax sale.
- Debt Reduction: Total debt decreased to $12.0 billion from $12.6 billion at year-end 2025. The company redeemed $508 million of 4.777% notes in June 2026 and $400 million of 1.400% notes in August 2026 (subsequent event).
Guidance, Outlook, and Risks
- Capital Allocation: The company has paused its share repurchase program and reduced its quarterly dividend by approximately 95% (to $0.03/share) to prioritize deleveraging. Management expects total capital expenditures for 2026 to be between $300 million and $350 million, focusing on stewardship and maintenance.
- Restructuring: The company is executing plant closures to streamline costs. It expects to incur an additional $60 million in exit and shutdown costs related to the Lanaken, Belgium facility through 2027.
- Market Risks: Demand remains muted in key end markets (automotive, construction) due to global macroeconomic weakness. The company faces risks from raw material price volatility (ethylene, methanol), currency fluctuations, and potential tariff impacts.
- Legal & Environmental: The company is defending against various litigation matters, including ethylene purchase claims in Europe (recently dismissed in some instances) and environmental remediation obligations (e.g., Diamond Alkali Superfund Site), though management does not expect these to be material to financial position.
Investor Verification Checklist
- Debt Covenants: Verify compliance with financial ratio maintenance covenants in credit facilities, especially given the high leverage and recent covenant amendments in July 2026.
- Working Capital Trends: Monitor the trajectory of trade receivables and inventory levels, which significantly impacted operating cash flow in the first half of 2026.
- Restructuring Execution: Track the actual costs and timeline of the Lanaken, Belgium closure and other announced plant shutdowns against the projected $60 million additional cost.
- Dividend Policy: Confirm if the reduced dividend ($0.03/share) remains the long-term policy or if it is a temporary measure pending further deleveraging.
- Legal Outcomes: Monitor the status of the European ethylene purchase claims and the appeal of the Diamond Alkali Superfund Site consent decree.